Anzeige
Mehr »
Dienstag, 25.11.2025 - Börsentäglich über 12.000 News
Goldrausch 2.0: 60% Insideranteil - warum dieser Gold-Explorer als Geheimtipp gilt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PCBP | ISIN: US10501L1061 | Ticker-Symbol:
NASDAQ
25.11.25 | 19:50
15,510 US-Dollar
+2,31 % +0,350
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BRAINSWAY LTD ADR Chart 1 Jahr
5-Tage-Chart
BRAINSWAY LTD ADR 5-Tage-Chart

Aktuelle News zur BRAINSWAY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13:36BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS Treatment December 1, 20251
17.11.BrainsWay Launches First Clinical Trial of Deep TMS 360 System for Alcohol Use Disorder1
13.11.FDA clears BrainsWay Deep TMS for depression in adolescents2
13.11.FDA approves BrainsWay's Deep TMS for adolescent depression treatment1
13.11.BrainsWay Receives FDA Clearance of Deep TMS as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 211
12.11.Brainsway Ltd. - 6-K, Report of foreign issuer-
11.11.Brainsway: EPS verfehlt Schätzungen um 0,01 $ - Umsatz besser als erwartet1
11.11.BrainsWay Ltd. Reports Rise In Q3 Profit-
BRAINSWAY Aktie jetzt für 0€ handeln
11.11.BrainsWay GAAP EPS of $0.04 in-line, revenue of $13.51M beats by $0.47M1
11.11.BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights246Revenue increased 29% to $13.5 million in Q3 2025 as compared with Q3 2024 Operating income totaled $1.3 million and Adjusted EBITDA rose approximately 80% to $2.0 million in Q3 2025, as compared...
► Artikel lesen
10.11.BrainsWay Q3 2025 Earnings Preview1
10.11.Insights into BrainsWay's Upcoming Earnings1
04.11.BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder2
04.11.Brainsway Ltd. - 6-K, Report of foreign issuer-
28.10.BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 20252
27.10.BrainsWay Makes Two Minority Investments In U.S. Mental Health Providers1
27.10.BrainsWay secures two more U.S. mental health provider investments1
27.10.BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers190Recent agreements with two additional U.S. mental health providers bring total to four in 2025 Strategy seeks to drive long-term shareholder value BURLINGTON, Mass. and JERUSALEM, Oct. 27, 2025 (GLOBE...
► Artikel lesen
27.10.Brainsway Ltd. - 6-K, Report of foreign issuer1
14.10.Brainsway Ltd. - 6-K, Report of foreign issuer1
Weiter >>
57 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1